NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001364

Registered date:09/09/2008

Phase II trial of TS-1 and cisplatin in patients with Carcinoma of Unknown Primary Sites (KMOG 0607)

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedCarcinoma of Unknown Primary Sites
Date of first enrollment2006/07/14
Target sample size38
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Treatment: TS-1+CDDP

Outcome(s)

Primary OutcomeResponse Rate
Secondary OutcomeSafety, Overall survival, Progression free survival

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria(1)Histological confirmation of cancer (2)Cancer of unknown primary sites (3)Measureable disease (4)ECOG PS 0~2 (5)Adequate major organ function (6)All patients provided written informed consent.
Exclude criteria(1)Massive pleural effusion or massive ascites (2)Symptomatic brain metastases

Related Information

Contact

public contact
Name Hitoshi Kusaba
Address 3-1-1 Maidashi, Higashi-ku, Fukuoka812-8582, Japan Japan
Telephone 092-642-5232
E-mail hkusaba@intmed1.med.kyushu-u.ac.jp
Affiliation Kyushu University Hospital Division of Hematology and Oncology
scientific contact
Name Eishi Baba
Address 3-1-1 Maidashi, Higashi-ku, Fukuoka812-8582, Japan Japan
Telephone 092-642-5232
E-mail e-baba@intmed1.med.kyushu-u.ac.jp
Affiliation Kyushu University Hospital Division of Hematology and Oncology